FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2022
Back to search
Official data from USPTO
GRINDEX GI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/25/2022
Trademark type
Combined
Nice classes
1, 3, 5, 35
Filing date
01/13/2021
Registration date
05/31/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
05/31/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
LV
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "GRINDEX" followed by a blank space and stylized "G" letter with a small "I" letter connected at the top.
Holders and representatives
Holders
GRINDEKS, akciju sabiedriba
Representatives
G PATRICK SAGE HUESCHEN & SAGE
Technical classification
Nice Classes
Class 1Class 3Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for use in the manufacture of pharmaceuticals; chemicals for use in the pharmaceutical industry
Class 3
Cosmetics; functional cosmetics; cosmetic preparations for skin care
Class 5
Pharmaceutical preparations in treating cancercardiovascular diseasesdiabetesnervous system diseasesanginaocular motility disordersattention deficit hyperactivity disordersymptoms of Insomniaantineoplastic and immunomodulating diseasesmusculoskeletal system diseasesdermatological diseasessensory organ diseaseshormonal disordersgenitourinary system disordersgynaecological disordersinfectious diseasesimmune system disordersconditions requiring antidopaminergic therapy; veterinary preparations for treating hormonal disordersgenitourinary disordersfor use as sedativesfor use as analgesicsfor use as muscle relaxantsfor use as anti sedativesfor use as anestheticsfor use in treating cardiovascular diseases; nutritional supplements; dietary supplements for humans; vitamins and vitamin preparations
Class 35
Advertising services
Publications
History of USPTO decisions and trademark events.
27 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
09/16/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
09/16/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/31/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
GPNX
NOTIFICATION PROCESSED BY IB
03/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/25/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/10/2022
ALIE
ASSIGNED TO LIE
02/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2022
RFNT
REFUSAL PROCESSED BY IB
08/22/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/02/2021
RFRR
REFUSAL PROCESSED BY MPU
08/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/27/2021
CNRT
NON-FINAL ACTION WRITTEN
07/26/2021
DOCK
ASSIGNED TO EXAMINER
07/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/04/2021
Continuous trademark protection
Get notified about every new filing that threatens GRINDEX GI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.